everyone probably has watched the recent video of Jeffery friedland talking about epidiolex-gwph's product.. that epidiolex could be classified or re-scheduled from class 1 and that the fda could approve epidiolex the summer of 2018...
so, gwph protected its ip and that is what owcp is doing -- I see very good things in the future for owcp and we shareholders if we just wait..
(1)
(0)
OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links